Skip to content
Screener
Q3 '26Q2 '26Q1 '26Q2 '25
$2.11M—$148K———$0—
$45.6M—$39.38M+30.7%——$30.13M—
$11.25M—$11.66M+82.3%——$6.39M—
$56.85M—$51.03M+39.7%——$36.52M—
-$54.74M—-$50.89M-39.3%——-$36.52M—
-2,589.2%—-34,382.4%—————
$124K—$210K-47.0%——$396K—
$10.25M—-$1.58M-192%——$1.71M—
-$44.49M—-$52.46M-50.7%-$45.32M-18.2%-$34.81M—
-2,104.6%—-35,448%—————
-$0.36—-$2.32+89.6%——-$22.28—
-$54.13M———————
-2,560.7%———————
-$54.74M—-$50.89M-39.3%——-$36.52M—

FAQ

Where does Parabilis Medicines's income statement data come from?
Every line is extracted from Parabilis Medicines's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.